Community pharmacies and other providers have been asked to prepare for this year’s spring Covid vaccine booster programme which should begin on 17 April and end on 30 June.
The campaign will offer booster vaccinations to those aged 75 and over, residents in care homes, and those aged five and over who are immunosuppressed.
Steve Russell, national director for vaccinations at NHS England, wrote on Friday to all community pharmacies, GP practices, ICBs, trust chief executives and others to set out the key principles of their spring booster planning.
He asked regional NHS teams to work with ICBs to run a ‘light-touch and rapid process’ to identify which sites can deliver the service, and confirmed that enhanced service specifications for community pharmacies and GPs will be published shortly.
The letter also highlights the importance of combating health inequalities: ‘Systems, working across their partnerships, must ensure equity of access and reduce unwarranted variation across communities through engagement activities to improve confidence and promote uptake, supported by appropriate access.’
During the autumn campaign, which ended on 12 February, 17 million Covid-19 boosters and over 20 million flu vaccines were delivered alongside maintaining routine immunisation programmes.
This extra booster vaccine dose in spring, as well as the groups who are eligible, is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI).
Following this campaign, community pharmacies and other providers should also prepare for an additional booster dose in autumn 2023, NHS England said.
The letter confirmed NHS England will manage booking of the spring booster via both local and national invites, and the National Booking System will open on 5 April.
Vaccination of adults in care homes will begin before the official start of the campaign, with NHS England asking systems to begin visits on 3 April.
Systems have also been asked to return plans to their regional colleagues by 10 March, and NHS England will shortly confirm the funding envelope for ‘costs associated with mobilisation’.
According to the letter, a longer-term plan for the vaccination strategy is being drawn up and will be published at some point this year.
A version of this article first appeared on our sister publication Pulse.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.